|
Author and year | County | Subject characteristics of treatment group | Subject characteristics of control group | Smoker |
Sample size | Gender | Age | Health status | BMI | weight | Sample size | Gender | Age | Health status | BMI | weight |
|
Ades et al. (2011) a [23] | USA | 23 | Both | 66 | Coronary heart disease | 32 | −8 | | | | | | | Not included |
Ades et al. (2011) b [23] | USA | 15 | Both | 62 | Coronary heart disease | 33 | −2 | | | | | | | Not included |
Baynard et al. (2009) a [24] | USA | 10 | Both | 52 | Metabolic syndrome | 34 | 0 | | | | | | | Not included |
Baynard et al. (2009) b [24] | USA | 10 | Both | 52 | Metabolic syndrome | 34 | 0 | | | | | | | Not included |
Baynard et al. (2009) c [24] | USA | 11 | Both | 53 | Healthy | 33 | 0 | | | | | | | Not included |
Baynard et al. (2009) d [24] | USA | 11 | Both | 53 | Healthy | 33 | 0 | | | | | | | Not included |
Bhutani et al. (2013) a [25] | USA | 18 | Both | 45 | Healthy | 35 | −6 | 25 | Both | 42 | Healthy | 35 | −3 | Not included |
Bhutani et al. (2013) b [25] | USA | 24 | Both | 42 | Healthy | 35 | −1 | 16 | Both | 49 | Healthy | 35 | 0 | Not included |
Blumenthal et al. (2010) [26] | USA | 49 | Both | 52 | HTN | 34 | −9 | 46 | Both | 52 | HTN | 33 | 0 | Included |
Choo et al. (2014) a [27] | South of Korea | 39 | Female | 42 | Healthy | 29 | −2 | | | | | | | Included |
Choo et al. (2014) b [27] | South of Korea | 39 | Female | 42 | Healthy | 29 | −2 | | | | | | | Included |
Choo et al. (2014) c [27] | South of Korea | 39 | Female | 42 | Healthy | 29 | −2 | | | | | | | Included |
Choo et al. (2014) d [27] | South of Korea | 26 | Female | 46 | Healthy | 28 | −2 | | | | | | | Included |
Choo et al. (2014) e [27] | South of Korea | 26 | Female | 46 | Healthy | 28 | −2 | | | | | | | Included |
Choo et al. (2014) f [27] | South of Korea | 26 | Female | 46 | Healthy | 28 | −1 | | | | | | | Included |
Choo et al. (2014) g [27] | South of Korea | 27 | Female | 42 | Healthy | 29 | −1 | | | | | | | Included |
Choo et al. (2014) h [27] | South of Korea | 27 | Female | 42 | Healthy | 29 | −1 | | | | | | | Included |
Choo et al. (2014) i [27] | South of Korea | 27 | Female | 42 | Healthy | 29 | −1 | | | | | | | Included |
Cotie et al. (2014) [28] | Canada | 20 | Female | 30 | Healthy | 32 | −6 | | | | | | | NR |
Davison et al. (2008) a [29] | Australia | 13 | Both | 45 | Healthy | 34 | 1 | 11 | Both | 44 | Healthy | 35 | 2 | |
Davison et al. (2008) b [29] | Australia | 13 | Both | 46 | Healthy | 33 | 1 | 12 | Both | 45 | Healthy | 33 | −2 | |
Fayh et al. (2013) [30] | Brazil | 17 | Both | 31 | Healthy | 35 | −4 | 18 | Both | 32 | Healthy | 35 | −5 | Not included |
Franklin et al. (2015) [31] | USA | 10 | Female | 30 | Healthy | 34 | −1 | 8 | Female | 31 | Healthy | 32 | 0 | Not included |
Hamdy et al. (2003) [32] | USA | 24 | Both | 49 | Insulin resistance syndrome | 37 | −7 | | | | | | | Not included |
Kwon et al. (2011) a [33] | South of Korea | 13 | Female | 56 | Type 2 diabetes | 27 | −2 | 15 | Female | 59 | Type 2 Diabetes | 27 | −1 | NR |
Kwon et al. (2011) b [33] | South of Korea | 12 | Female | 56 | Type 2 diabetes | 27 | −1 | 15 | Female | 59 | Type 2 Diabetes | 27 | −1 | NR |
Olson et al. (2006) [34] | USA | 15 | Female | 38 | Healthy | 28 | 2 | 15 | Female | 38 | Healthy | 28 | 0 | Not included |
Pugh et al. (2014) [35] | UK | 13 | Both | 50 | Nonalcoholic fatty liver disease | 30 | −2 | 8 | Both | 47 | Healthy | 30 | −1 | |
Robinson et al. (2016) [36] | USA | 10 | Both | 34 | Healthy | 32 | −3 | 9 | Both | 28 | | 33 | 0 | Not included |
Swift et al. (2012) a [37] | USA | 68 | Female | 57 | Elevated BP | 32 | −1 | 23 | Female | 57 | Elevated BP | 32 | −1 | |
Swift et al. (2012) b [37] | USA | 32 | Female | 56 | Elevated BP | 33 | −1 | 23 | Female | 57 | Elevated BP | 32 | −1 | |
Swift et al. (2012) c [37] | USA | 32 | Female | 56 | Elevated BP | 31 | −1 | 23 | Female | 57 | Elevated BP | 32 | −1 | |
Vinet et al. (2011) [38] | France | 10 | Male | 51 | Healthy | 33 | −2 | | | | | | | Not included |
Wycherley et al. (2008) [39] | Australia | 13 | Both | 52 | Type 2 diabetes | 34 | −8 | 16 | Both | 53 | Type 2 Diabetes | 35 | −9 | |
|